Aducanumab: Dr Terry Quinn explains approval of new Alzheimer’s disease drug SDRC Executive Committee member, Dr Terry Quinn, Terry takes us through all the important facts behind the recent announcement by the FDA in the US to approve aducanumab for the...
Care home lockdown and the impact on families: what hurt, what helped and what happens next At the end of last year, we published a researcher blog from those involved in the Creative Covid Care study. This blog outlined their work on the experiences of...
NHS Research Scotland (NRS) has funded a small bid from the Universities of Edinburgh, Aberdeen, Dundee and Glasgow to run some Patient Public Involvement (PPI) Workshops. The idea of the workshops is to have a collective dialogue about how we progress PPI in...
Our final announcement of new SDRC Executive Committee members is Stina Saunders. We are delighted to have Stina joining us and look forward to working with her and all the new members. Find out more about Stina in the blog below. I am in the final year of my PhD at...
This year Alzheimer’s Disease International has commissioned McGill University, Montreal, Canada to produce this year’s World Alzheimer Report on diagnosis, as well as the 2022 World Alzheimer Report on post-diagnostic support. The first of three surveys...
Following our recent SDRC Executive Committee election, we have seven new researchers join us. The full list of members is available here. We are delighted to announce Dr Tom Russ as one of the newest members. Find out more about Tom below. I trained in medicine and...
